Clinical Trials Study
Copyright ©The Author(s) 2022.
World J Clin Cases. Nov 6, 2022; 10(31): 11391-11402
Published online Nov 6, 2022. doi: 10.12998/wjcc.v10.i31.11391
Table 4 Comparison of adverse events between the two groups
ItemControl group
TCM group
P value
n = 38
Percent (%)
n = 40
Percent (%)
Gastroenteritis2463.11230.00.006
Anemia513.125.00.970
Hepatic function damage1642.1922.50.030
Leukopenia37.8000.060
Upper respiratory infection513.1717.50.590
Phlebothrombosis25.3000.140
Urinary infection12.6000.300
Hypothyroidism37.912.50.280
Hypertension1026.337.50.020